Literature DB >> 27504339

Systemic Sclerosis with Multiple Pulmonary Manifestations.

Mohan Rao Kotnur1, Parinita Suresh2, Venkata Siva Prasad Reddy2, Tarun Sharma2, Nabil Ahmed Salim2.   

Abstract

Systemic sclerosis (SSc) is a chronic autoimmune multisystem disorder characterized by endothelial dysfunction and fibroblast dysfunction, which results in progressive fibrosis of the skin and internal organs more frequently the lungs and gastro intestinal tract. Pulmonary involvement is common in the course of SSc, with Interstitial Lung Disease (ILD) and Pulmonary Arterial Hypertension (PAH) being the leading causes of death. Here we report, case of an elderly female patient presenting with Diffuse SSc with multiple uncommon pulmonary manifestations like ILD with Usual Interstitial Pneumonia (UIP) pattern (usually less common), PAH and right sided pleural effusion.

Entities:  

Keywords:  Interstitial lung disease; Pulmonary arterial hypertension; Scleroderma; Usual interstitial pneumonia

Year:  2016        PMID: 27504339      PMCID: PMC4963699          DOI: 10.7860/JCDR/2016/18781.8032

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  6 in total

Review 1.  Scleroderma.

Authors:  Armando Gabrielli; Enrico V Avvedimento; Thomas Krieg
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

2.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

3.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

4.  A study of the frequency of pericardial and pleural effusions in scleroderma.

Authors:  A E Thompson; J E Pope
Journal:  Br J Rheumatol       Date:  1998-12

5.  Scleroderma patients with combined pulmonary hypertension and interstitial lung disease.

Authors:  Betty Chang; Fredrick M Wigley; Barbara White; Robert A Wise
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

6.  High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease.

Authors:  Jonathan G Goldin; David A Lynch; Diane C Strollo; Robert D Suh; Dean E Schraufnagel; Philip J Clements; Robert M Elashoff; Daniel E Furst; Sarinnapha Vasunilashorn; Michael F McNitt-Gray; Mathew S Brown; Michael D Roth; Donald P Tashkin
Journal:  Chest       Date:  2008-07-18       Impact factor: 9.410

  6 in total
  2 in total

Review 1.  Determinants of mortality in systemic sclerosis: a focused review.

Authors:  Dilli Ram Poudel; Divya Jayakumar; Abhijeet Danve; Shiv Tej Sehra; Chris T Derk
Journal:  Rheumatol Int       Date:  2017-11-07       Impact factor: 2.631

2.  Fatal consequences of therapeutic thoracentesis in patients with systemic sclerosis.

Authors:  Tsvi Sirotkin; Aiman Natour; Ori Wand; Yair Levy
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-09-30       Impact factor: 0.670

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.